Abstract:We present an unusual case of a patient with bilateral-lung transplantation due to severe coronavirus disease 2019 (COVID-19), who subsequently suffered complications with acute myocardial infarction and underwent primary percutaneous coronary intervention (PCI). A 70-year-old man presented with fever, cough, and dyspnea after returning from Hubei Province at the end of Jan. 2020. The diagnosis of COVID-19 had been confirmed by the nucleic acid test at a local hospital on Feb. 2, 2020. He had a history of mild hypertension and Type 2 diabetes without regular medication. He was a current smoker but denied the history of ischemic heart disease or hyperlipidemia. Despite initial treatment with methylprednisolone, umifenovir, and darunavir, the patient’s condition worsened with continued dyspnea and persisting fever. On Feb. 9 (Day 7 after symptoms onset), the patient was transferred to the intensive care unit (ICU) of our hospital. On arrival, the patient’s vital signs were stable except for tachypnoea at 27 min. Key laboratory results were: white blood cell count, 6.6×10 L; neutrophil, 89.1%; hemoglobin, 129 g/L; platelet count, 180×10 L; creatinine, 64 μmol/L; high sensitive C reaction protein (hs-CRP), 45.51 mg/L. chest computed tomography (CT) scan showed bilateral diffuse infiltration. After admission, he was treated with high-flow nasal oxygen, methylprednisolone, umifenovir, piperacillin, and tazobactam. On Feb. 14 (Day 12), he was intubated due to severe hypoxia. On Feb. 22 (Day 20), repeated nucleic acid tests for 2019 novel coronavirus (2019-nCoV) in sputum and bronchoalveolar lavage fluid were all negative; however, his condition continued to deteriorate due to pulmonary consolidation complicated by Stenotrophomonas maltophilia infection. We began venovenous extracorporeal membrane oxygenation (ECMO) treatment on Feb. 26 (Day 24). A CT scan on Mar. 2 (Day 29) revealed significant progression of pulmonary consolidation (Fig. 1). A bilateral-lung transplantation was performed on Mar. 8 (Day 34) after multidisciplinary discussion. Postoperatively, the ECMO was withdrawn since the oxygenation had been improved and the patient’s general condition was more stable. A continuous renal replacement therapy (CRRT) was started on Mar. 10 (Day 36/Day 2 postoperative) to support renal function. On Mar. 11 (Day 3 postoperative), laboratory results were: hemoglobin, 80 g/L; platelet count, 36×10 L; creatinine, 103 μmol/L; international normalized ratio (INR), 1.77; activated partial thromboplastin time (APTT), 45.9 s; prothrombin time (PT), 20.8 s; D-dimer, 2927.00 μg/L. On Mar. 12 at 9:00 a.m. (Day 4 postoperative), the patient developed a sudden episode of ventricular fibrillation. After cardiopulmonary resuscitation with Journal of Zhejiang University-SCIENCE B (Biomedicine & Biotechnology) ISSN 1673-1581 (Print); ISSN 1862-1783 (Online) www.jzus.zju.edu.cn; www.springerlink.com E-mail: jzus@zju.edu.cn

First lung and kidney multi-organ transplant following COVID-19 Infection

LUNG TRANSPLANTATION DURING THE OUTBREAK OF CORONAVIRUS DISEASE 2019: EARLY EXPERIENCE FROM CHINA

Lung transplantation during the outbreak of Coronavirus Disease 2019 in China

Primary Percutaneous Coronary Intervention in a COVID-19 Patient with ST-segment Elevation Myocardial Infarction after Lung Transplantation: a Case Report

A Multi‐Center International Analysis of Lung Transplantation Outcomes in Patients With COVID‐19

A Single-center Experience With >200 Lung Transplant Recipients With COVID-19 Infection

LUNG TRANSPLANTATION FOR AN ARDS PATIENT POST-COVID-19 INFECTION

Early Experience With COVID-19 and Solid Organ Transplantation at a US High-volume Transplant Center

Lung Transplant Recipients and COVID-19: Report of Two Cases

Lung Transplantation in the United States for COVID-19 Related Lung Disease During the Pandemic

Novel Insight from the First Lung Transplant of a COVID-19 Patient

Lung Transplantation As Therapeutic Option in Acute Respiratory Distress Syndrome for Coronavirus Disease 2019-Related Pulmonary Fibrosis.

Lung transplantation in patients with lung disease secondary to coronavirus disease 2019 infection

Early Outcomes of COVID-19 Lung Transplantation Recipients in Korea: A Single-Center Study

Bilateral lobar lung transplantation and a single lung transplantation using lungs from a single organ donor during coronavirus disease 2019 pandemic

Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort Study

First Lung Transplant in Wuhan for a Critical and Elderly COVID‐19 Patient

Outcomes Following Lung Transplant for COVID-19-Related Complications in the US

Functional improvements of patients admitted to an inpatient rehabilitation facility after bilateral lung transplant due to severe COVID-19 pulmonary disease

Lung transplantation for patients with severe COVID-19

Practical experiences of managing COVID-19 in lung transplantation